» Articles » PMID: 36231937

Retinal and Choroidal Effects of Continuous Positive Airway Pressure As Treatment for Sleep Apnea: Results at 12 Months

Overview
Publisher MDPI
Date 2022 Oct 14
PMID 36231937
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To determine the impacts of continuous positive airway pressure (CPAP) treatment on retinal and choroidal thickness measurement in individuals with obstructive sleep apnea (OSA).

Methods: Participants were 28 patients with OSA treated with CPAP who were enrolled immediately after diagnosis and graded according to the apnea hypopnea index (AHI) determined in an overnight polysomnography. Inclusion criteria were a new diagnosis of OSA and an indication for CPAP. Participants underwent a full ophthalmologic examination including standard automated perimetry (SAP) and optical coherence tomography (OCT) at the levels peripapillary, macular, and choroidal before CPAP onset, and after three and twelve months of CPAP. The data compared before and after treatment were intraocular pressure, SAP, and the thicknesses peripapillary retinal nerve fiber layer (pRNFL), total retinal (TR), retinal ganglion cell layer (RGCL), inner plexiform layer (IPL), photoreceptor layer (PL), and choroidal.

Results: After 3 months of CPAP, we observed thickening of the pRNFL (in 5/6 subfields) ( < 0.004) and TR (in 5/9 subfields) ( < 0.010). At 12 months, thickening persisted in these layers, this time affecting 2/6 and 2/9 subfields, respectively ( < 0.012 and < 0.001, respectively). Choroidal thinning was observed at the temporal level at both 3 and 12 months compared to measurements before starting CPAP treatment ( = 0.014 and = 0.038, respectively). SAP remained unchanged. Intraocular pressure was higher at 12 months than at 3 months ( = 0.001).

Conclusions: 12 months of CPAP avoids retinal thinning and normalizes choroidal thickness in OSA patients.

Citing Articles

Retinal microvascular phenotypes can track small vessel disease burden and CPAP treatment effectiveness in obstructive sleep apnoea.

Giarratano Y, Hill E, Hamid C, Wiseman S, Gray C, Chappell F J Cereb Blood Flow Metab. 2024; :271678X241291958.

PMID: 39487754 PMC: 11563513. DOI: 10.1177/0271678X241291958.


Reply to La Marca et al. Comment on "Naranjo-Bonilla et al. Retinal and Choroidal Effects of Continuous Positive Airway Pressure as Treatment for Sleep Apnea: Results at 12 Months. 2022, , 12637".

Naranjo-Bonilla P, Gimenez-Gomez R, Munoz-Villanueva M, Jurado-Gamez B Int J Environ Res Public Health. 2023; 20(2).

PMID: 36673899 PMC: 9858898. DOI: 10.3390/ijerph20021141.


Comment on Naranjo-Bonilla et al. Retinal and Choroidal Effects of Continuous Positive Airway Pressure as Treatment for Sleep Apnea: Results at 12 Months. 2022, , 12637.

La Marca A, Biondino D, Gioia M Int J Environ Res Public Health. 2023; 20(2).

PMID: 36673897 PMC: 9859568. DOI: 10.3390/ijerph20021139.

References
1.
Wang J, Xie H, Jia Y, Zhang M . Retinal nerve fiber layer thickness changes in obstructive sleep apnea syndrome: a systematic review and Meta-analysis. Int J Ophthalmol. 2016; 9(11):1651-1656. PMC: 5145096. DOI: 10.18240/ijo.2016.11.19. View

2.
Kivela T, Hietanen J, Uusitalo M . Autopsy analysis of clinically unilateral exfoliation syndrome. Invest Ophthalmol Vis Sci. 1997; 38(10):2008-15. View

3.
Medeiros F, Lisboa R, Weinreb R, Liebmann J, Girkin C, Zangwill L . Retinal ganglion cell count estimates associated with early development of visual field defects in glaucoma. Ophthalmology. 2012; 120(4):736-44. PMC: 3804164. DOI: 10.1016/j.ophtha.2012.09.039. View

4.
Zengin M, Tuncer I, Karahan E . Retinal nerve fiber layer thickness changes in obstructive sleep apnea syndrome: one year follow-up results. Int J Ophthalmol. 2014; 7(4):704-8. PMC: 4137211. DOI: 10.3980/j.issn.2222-3959.2014.04.22. View

5.
Mojon D, Hess C, Goldblum D, Fleischhauer J, Koerner F, Bassetti C . High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology. 1999; 106(5):1009-12. DOI: 10.1016/S0161-6420(99)00525-4. View